S&P 500

5.308,27

0,00%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
Canadá
TSX
Fennec Pharmaceuticals Inc (FRX)
Fennec Pharmaceuticals Inc (FRX) Notícias

FRX

Fennec Pharmaceuticals (FRX)

Fennec Pharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:TSX:FRX

1

Data	Hora	Fonte	Título	Código	Companhia
18/03/2024	04:00	PR Newswire (US)	Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand	TSX:FRX	Fennec Pharmaceuticals Inc
13/09/2017	13:39	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
13/09/2017	13:35	PR Newswire (Canada)	IIROC Trade Resumption - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
13/09/2017	10:32	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
13/09/2017	10:29	PR Newswire (Canada)	IIROC Trading Halt - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
01/06/2015	12:00	PR Newswire (US)	Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting	TSX:FRX	Fennec Pharmaceuticals Inc
27/08/2009	19:31	PR Newswire (US)	Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduce	NYSE:FRX
10/08/2009	08:00	PR Newswire (US)	Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD	NYSE:FRX
22/06/2009	10:20	PR Newswire (US)	Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham	NYSE:FRX
20/05/2008	12:30	PR Newswire (US)	Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic f	NYSE:FRX
08/11/2007	11:30	PR Newswire (US)	Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show	NYSE:FRX
01/05/2007	12:49	PR Newswire (US)	Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol	NYSE:FRX
15/02/2006	21:07	PR Newswire (US)	/C O R R E C T I O N -- Forest Laboratories, Inc./	NYSE:FRX